Business Aniket Pujari September 14, 2026 Novo Rebrands and Refines Global Strategy as Race for Obesity Market Dominance Escalates Novo Nordisk unveils a major corporate rebranding to Novo as CEO Mike Doustdar outlines a revised obesity strategy to address rising competition from Eli Lilly. Read More
